Quantcast

Posts related to ‘Exubera’

Nektar Crushed Under Pfizer’s Boot (NKTR, PFE)

Posted: October 18, 2007 at 9:29 am

Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would end its involvement in inhaled diabetes drug Exubera and return ...
Read Full Story »